Request For Information - Administrative, Scientific, and Technical Support Services of the Chemical, Biological Radiological, & Nuclear Defense Research Coordinating Office
ID: EMO-25-0001Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Other Scientific and Technical Consulting Services (541690)

PSC

SUPPORT- PROFESSIONAL: PROGRAM EVALUATION/REVIEW/DEVELOPMENT (R410)

Original Source

https://sam.gov/opp/4404901f4c624f69aa5955ad5c600acd/view
Timeline
    Description

    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking information from vendors regarding Administrative, Scientific, and Technical Support Services for the Chemical, Biological, Radiological, and Nuclear Defense Research Coordinating Office (CBRN DCO). The primary objectives include management and administration support, meeting and conference facilitation, research and analysis assistance, and financial support services, all of which require personnel to hold active SECRET clearances. This opportunity is crucial for enhancing defense capabilities through coordinated medical research and management expertise, with a contract period of one base year and up to four option years anticipated. Interested vendors must submit a Capability Statement by February 4, 2025, to Ms. Elizabeth O'Hara at elizabeth.m.ohara3.civ@health.mil, as this RFI does not imply a commitment to procure services nor will costs incurred in response be reimbursable.

    Point(s) of Contact
    Elizabeth O'Hara
    elizabeth.m.ohara3.civ@health.mil
    Files
    Title
    Posted
    CBRN DCO PWS.pdf
    The Performance Work Statement (PWS) for the Chemical, Biological, Radiological, and Nuclear Defense Research Coordinating Office (CBRN DCO) outlines the need for administrative, scientific, and technical support services. The CBRN DCO, part of the U.S. Army Medical Research and Development Command (USAMRDC), coordinates critical defense research and partnerships. Key objectives include managing day-to-day operations, providing research and analysis support, and executing financial management. The contract covers a period of one base year with up to four option years, requiring the contractor to maintain a non-personal services relationship with the government. Personnel must include experts in medical research and financial management, and all personnel must hold security clearances. Deliverables include monthly reports, technical documentation, and meeting summaries. Contractors are expected to adhere to strict security and training protocols. The document emphasizes the importance of maintaining seamless transitions during contract phases and outlines the responsibilities for subcontractor management and compliance with federal acquisition regulations. Overall, the PWS serves as a foundation for enhancing defense capabilities through well-coordinated medical research support and management expertise.
    CBRN DCO Support Services RFI.pdf
    The U.S. Army Medical Research and Development Command is seeking input via a Request for Information/Sources Sought (RFI/SS) for Administrative, Scientific, and Technical Support Services related to Chemical, Biological, Radiological, and Nuclear Defense. This inquiry aims to assess vendor capabilities and interest for a potential future Request for Proposal (RFP). The required services include management and administration support, conference and meeting facilitation, research and analysis assistance, and financial support services. All personnel must hold active SECRET clearances, and the detailed tasks are outlined in the draft Performance Work Statement (PWS). Vendors are instructed to submit a Capability Statement, including organizational details, relevant experience, and specific expertise in areas highlighted in the PWS. The submission deadline is set for February 4, 2025. This RFI/SS is primarily informational and does not imply a commitment to procure services, nor will costs incurred in response be reimbursable.
    Similar Opportunities
    DTRA CWMD Security Cooperation Engagement Program IDIQ
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is seeking contractors for the Countering Weapons of Mass Destruction (CWMD) Security Cooperation Engagement Program (CSCEP) through an Indefinite Delivery Indefinite Quantity (IDIQ) contract. This program aims to enhance the capabilities of partner nations in responding to Chemical, Biological, Radiological, and Nuclear (CBRN) incidents, thereby improving global national security. The contractor will be responsible for training, equipping, and supporting partner nations, including logistics management and event planning, with a focus on compliance with U.S. and international regulations. Interested parties should note that the solicitation will be released in the second quarter of fiscal year 2025, and inquiries can be directed to Jocelyn Fritz or Eric M Rode at the provided email address.
    Biomedical Research Application Evaluation and Support Services (BRAES)
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking information regarding Biomedical Research Application Evaluation and Support Services (BRAES) as part of a market research initiative. The objective is to support the Congressionally Directed Medical Research Programs (CDMRP) by managing biomedical research funding, which includes a two-tier review process and the development of a Quality Control Plan. This opportunity is crucial for ensuring the integrity and efficiency of the application evaluation process, utilizing government-furnished systems for application processing and award management. Interested parties must submit their responses to the Request for Information (RFI) by 12:00 p.m. Eastern Time on December 15, 2025, to Ms. Deanna S. Moose at deanna.s.moose.civ@health.mil, adhering to the specified guidelines and page limits.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), has issued a Broad Agency Announcement (BAA) to solicit proposals for innovative research and development in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. This solicitation is open continuously for up to five years and invites proposals from educational institutions, nonprofit organizations, and private industry, focusing on areas such as detection technologies, modeling and simulation, and countermeasures to terrorism. The BAA is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' dominance on the battlefield and homeland defense. Interested parties can contact Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil or Lionel Love at lionel.d.love.civ@army.mil for further information regarding proposal submissions and evaluation criteria.
    DRAFT: OB BP IDIQ
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is seeking qualified contractors for the DRAFT: OB BP IDIQ opportunity, aimed at enhancing the capacity of partner nations to counter weapons of mass destruction (WMD) and chemical, biological, radiological, and nuclear (CBRN) threats. The contract will primarily support DTRA's Countering-WMD Security Cooperation Engagement Program (CSCEP) and the International Counterproliferation Program (ICP), focusing on establishing or enhancing partner nation capabilities to deter, detect, interdict, or respond to WMD proliferation. This initiative is critical for the Department of Defense and U.S. Government in their efforts to deter strategic attacks and prevail against WMD-armed adversaries. Interested parties can reach out to primary contact Jocelyn Fritz at jocelyn.m.fritz.civ@mail.mil or 571-616-5277, or secondary contact Eric Rode at eric.m.rode.civ@mail.mil or 571-616-6145 for further information. The final Request for Proposal (RFP) is expected to be issued before the end of the fiscal year, with updates available on the SAM.gov entry.
    W9127826SSN2511-MRDC O&M with Repair and Minor Construction
    Dept Of Defense
    The Department of Defense, through the U.S. Army Corps of Engineers (USACE) Mobile District, is seeking information from potential contractors for a Firm-Fixed-Price contract to provide operation and maintenance (O&M) services, along with repair and minor construction, in support of the Defense Health Agency (DHA) Medical Research and Development Command (MRDC) at multiple locations. The contract will require 24/7 support for various medical, dental, pharmacy, and laboratory facilities, necessitating extensive knowledge of medical facility operations and compliance with Joint Commission standards. Interested contractors should note that this is a Sources Sought Notice for market research purposes only, with no solicitation currently available; responses are due by December 8, 2025, and inquiries can be directed to Tiffany Williams at Tiffany.N.Williams@usace.army.mil or the CT-M Inbox at ct-cproposals-medcom@usace.army.mil.
    Radiopharmaceutical Laboratory Services (RLS) MAMC
    Dept Of Defense
    The Department of Defense, specifically the Madigan Army Medical Center, is conducting market research to identify qualified vendors capable of providing comprehensive Radiopharmaceutical Laboratory Services (RLS). The procurement aims to ensure that vendors can meet stringent requirements, including compliance with FDA standards, The Joint Commission accreditation, and the ability to deliver a range of specified radiopharmaceuticals on a 24/7 basis, including urgent requests. These services are critical for supporting medical operations that rely on radiopharmaceuticals for diagnostics and treatment. Interested parties must submit their capability statements to Cindy Means and Scott Barr by December 19, 2025, at 4:00 PM Pacific Time, detailing their qualifications and ability to meet the outlined requirements.
    JPEO-CBRND RFI - Innovation in Biologics Manufacturing
    Dept Of Defense
    The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is issuing a Request for Information (RFI) focused on innovations in biologics manufacturing. This RFI seeks information on capabilities and technologies related to biologics manufacturing, specifically targeting cell-free production capabilities, advancements in process control, and methods to expedite drug substance release. The initiative aims to enhance medical solutions for crisis response and improve preparedness against future threats. Interested parties are encouraged to share their capabilities via the Joint Enterprise Technology Tool (JETT) platform, with no commitment from the government to issue a subsequent Request for Proposal (RFP).
    BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is conducting market research for the development of a barrier combination product aimed at preventing and treating battlefield wounds and subsequent infections. This initiative, part of the Battlefield Wound Infection Prevention and Treatment (BWI P&T) program, seeks to identify commercial solutions that can effectively address the unique challenges of wound care in austere environments, where medical resources may be limited. The barrier combination product is expected to play a crucial role in a Family of Systems (FoS) approach, providing innovative solutions for both military and commercial applications in wound care. Interested parties are invited to submit their responses by January 20, 2026, at 2:00 PM Eastern, via email to the primary contacts, Jeanette Collins and Julie Burns, whose emails are provided in the opportunity overview. This RFI is for planning purposes only, and no contract will be awarded based on the responses received.
    Microbial Identification System (MIS)
    Dept Of Defense
    The Department of Defense, through the United States Army Health Contracting Activity, is seeking information regarding a commercial solution for a Microbial Identification System (MIS) to enhance its MicroScan autoSCAN-4 System. The objective is to procure a system that meets the Critical Operational Device Specifications (CODS), which include operational characteristics, support for specific testing panels, and compatibility with a LabPro computer running Windows 11. This procurement is crucial for ensuring reliable laboratory systems in medical environments, particularly in austere settings. Interested vendors must submit their responses by 4:00 PM Central Time on April 3, 2025, to Linda McGhee at linda.a.mcghee.civ@health.mil, and are encouraged to provide detailed information about their capabilities and products as outlined in the RFI documents.
    Research and Development Services for Research Study titled "Mechanisms of RF Interaction with Biological Systems."
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking research and development services for a study titled "Mechanisms of RF Interaction with Biological Systems," to be conducted at the United States Air Force 59th Medical Wing in San Antonio, Texas. The objective of this research is to investigate the effects of directed energy injuries on military personnel by examining the interactions between radiofrequency overexposure and biological systems, utilizing miniature swine animal models to identify novel biomarkers and clinically translatable outcomes. This study is crucial for understanding and mitigating potential health risks associated with high-power microwave exposure. Interested parties are invited to submit a Capability Statement, limited to five pages, detailing their relevant experience and capabilities by December 22, 2025, at 12:00 PM Eastern Time, to Mr. Brandon Clingan and Mr. Jeremy McMurry via email.